Cynthia Goldstein demonstrates how to use the new inhalable insulin drug that helps treat her diabetes. Photo: TNS
It took 10 years and US$1bil (RM3.77bil) for MannKind Corp to get its breakthrough inhaled-insulin drug approved by US regulators.
Now comes the hard part: getting people with diabetes to use it.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
